Skip to main content

Posts

Locum GP Inside IR35 Calculator: True Take-Home Pay 2026/27

Locum GP Inside IR35 Calculator: True Take-Home Pay 2026/27 IR35 Locum Rate Audit Independent pay estimate 2026/27 tax year For locum GPs & consultants What is that Inside IR35 rate really worth? See how an advertised assignment rate becomes taxable salary, then compare it with the money likely to reach your bank account. Placement details Your advertised rate Reset Assignment rate £ Hourly Daily Paid hours per day 8 hours Hours worked each week hours Paid weeks per year weeks Umbrella margin £ per paid week Calculation assumptions England, Wales or Northern Ireland; standard 1257L-equivalent personal allowance; one employment; no pension, student loan, expenses or be...
Recent posts

NHS Take-Home Pay Calculator 2026/27 | Tax, NI & Pension

NHS TAKE-HOME PAY 2026/27 NHS Take-Home Pay Calculator Calculate estimated NHS monthly take-home pay for England, Wales or Scotland using 2026/27 Agenda for Change pay scales, regional Income Tax, employee National Insurance, tiered NHS pension contributions and student-loan deductions. How much will you actually take home from your NHS salary? An NHS annual salary does not tell you what will reach your bank account each month. Your net pay can change because of Income Tax, National Insurance, NHS Pension Scheme contributions, student loans, postgraduate loans, part-time hours, London weighting and additional pensionable or non-pensionable earnings. Scotland also has its own Income Tax bands and its own NHS pension contribution tiers. This calculator brings those factors together in one place. Choose England, Wales or Scotland , select your Agenda for Change band and pay point, adjust your contracted hours and deductions, then view a...

Melanoma Vaccine: How the New Personalised mRNA Cancer Vaccine Works

Last updated: 20 August 2026 For years, the idea of making a cancer vaccine specifically for one individual sounded more like a glimpse of future medicine than something likely to enter ordinary cancer care. Melanoma may now be one of the cancers that changes that. A personalised mRNA treatment known as intismeran autogene , previously called V940 or mRNA-4157 , is being developed by Moderna and Merck, known as MSD outside the United States and Canada. It is designed from the genetic mutations found inside an individual patient's melanoma and given alongside the immunotherapy drug pembrolizumab, or Keytruda . The results have attracted considerable attention because this is not simply another laboratory experiment. A randomised phase IIb study produced encouraging results that remained durable after five years of follow-up. Then, on 19 August 2026, Moderna and Merck announced that their much larger phase III INTerpath-001 trial had met its main endpoint, showing a statis...